학술논문
Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR
Document Type
Article
Author
Source
In Blood 10 January 2019 133(2):147-155
Subject
Language
ISSN
0006-4971